An ELISpot analysis of cells secreting IL-17A amd Bovine PBMC incubated overnight in the presence (40,000 cells per well) or absence (200,000 cells per well) of PHA.
Recombinant humanized monoclonal antibody to IL-17A for use as a research grade Ixekizumab biosimila for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant humanized monoclonal antibody to IL-17A for use as a research grade Xeligekimab biosimil for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant humanized monoclonal antibody to IL-17A for use as a research grade Gumokimab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant humanized monoclonal antibody to IL-17A for use as a research grade Netakimab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant human monoclonal antibody to IL-17A for use as a research grade Secukinumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant humanized monoclonal antibody to IL-17A for use as a research grade Ixekizumab biosimila for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant humanized monoclonal antibody to IL-17A for use as a research grade Xeligekimab biosimil for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant humanized monoclonal antibody to IL-17A for use as a research grade Gumokimab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant humanized monoclonal antibody to IL-17A for use as a research grade Netakimab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant human monoclonal antibody to IL-17A for use as a research grade Secukinumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.